Retinol fades hyperpigmentation by speeding up cell turnover. It can take a couple of months to really show its work, but you ...

BERLIN -- A single infusion of the investigational PRAME-directed T-cell receptor T-cell therapy anzutresgene autoleucel (anzu-cel) showed encouraging antitumor activity in patients with previously ...

Around a third of people over the age of 80 suffer from age-related macular degeneration (AMD), with an estimated 20 million Americans aged 40 and older currently living with AMD. Most cases are the ...

How ubiquitous is anime? It’s now being used to treat lazy eye in children. Anime giant Crunchyroll has partnered with Luminopia, a digital health company that devises new treatments for significant ...

Go ahead and toss those eye patches. By Tony Maglio How ubiquitous is anime? It’s now being used to treat lazy eye in children. Anime giant Crunchyroll has partnered with Luminopia, a digital health ...

Kala Bio missed the primary endpoint in the study for its treatment of Persistent Corneal Epithelial Defect, an eye defect, and said it would stop development of the drug, called KPI-012. The company ...

An mRNA vaccine developed by researchers from Japan suppressed abnormal blood vessel growth or neovascularization in the retina of mouse models. Neovascularization is a condition that is caused by age ...

Northwestern Medicine announced Tuesday that for the first time, its doctors have successfully treated metastatic eye cancer using a method that delivers chemotherapy directly to the liver. The ...

The Aroma Season eye mask is filled with natural flax seeds to offer a slightly compressive, non-toxic remedy and a design that molds into those awkward gaps around the eyes and nose, which means ...

The company’s product releases cell therapy into the eye via injection to slow down vision loss Clinical-stage biotech company jCyte Inc. is developing its cell therapy treatment jCell for retinitis ...

Erin Jensen, Valeda coordinator at Bergstrom Eye Clinic, administers red light therapy to Anna Marie Johnson of Fargo. The new FDA-approved treatment stimulates cellular activity in the retina for ...